Table 1 Characteristics of the study population categorized by HPV52 (sub)lineage
HPV52 (sub)lineages | Normal (n = 67) | CIN1 (n = 53) | CIN2 (n = 45) | CIN3 (n = 24) | Cancer (n = 0) | Total (n = 189) |
|---|---|---|---|---|---|---|
A1 | 2 (3.0%) | 1 (1.9%) | 1 (2.2%) | 0 | 0 | 4 (2.1%) |
A2 | 0 | 0 | 0 | 0 | 0 | 0 |
B | 64 (95.5%) | 52 (98.1%) | 42 (93.3%) | 23 (95.8%) | 0 | 181 (95.8%) |
52CNTZ05 | 39 (58.2%) | 31 (58.5%) | 26 (57.8%) | 12 (50.0%) | 0 | 108 (57.1%) |
52CNTZ12 | 16 (23.9%) | 15 (28.3%) | 8 (17.8%) | 8 (33.3%) | 0 | 47 (24.9%) |
52CNTZ17 | 2 (3.0%) | 2 (3.8%) | 2 (4.4%) | 0 | 0 | 6 (3.2%) |
52CNTZ21 | 2 (3.0%) | 0 | 3 (6.7%) | 0 | 0 | 5 (2.6%) |
Other | 5 (7.5%) | 4 (7.5%) | 3 (6.7%) | 3 (12.5%) | 0 | 15 (7.9%) |
C1 | 0 | 0 | 0 | 0 | 0 | 0 |
C2 | 1 (1.5%) | 0 | 2 (4.4%) | 1 (4.2%) | 0 | 4 (2.1%) |
D | 0 | 0 | 0 | 0 | 0 | 0 |